Related Experiment Video
Updated: Jun 6, 2026
08:27
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS
1Senior Research Manager, Biochemical Technologies, Science and Technology Division, Corning Inc., Sullivan Park, Corning, NY 14831, Tele: 607-9747203, , fangy2@corning.com.
Expert Opinion on Drug Discovery
|November 30, 2010
Summary
Cancer is a pathway dysregulated disease. Resonant waveguide grating (RWG) biosensor assays offer insights into cancer biology, aiding the development of targeted therapies and diagnostics.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Cancer arises from accumulated genetic alterations, but protein signaling pathways are central to aberrant cell growth.
- Understanding functional consequences of dysregulated signaling proteins in native networks is crucial for cancer research.
Purpose of the Study:
- Review the integrative nature of resonant waveguide grating (RWG) biosensor cellular assays.
- Explore RWG biosensor applications in identifying cancer cell surface markers and core signaling pathways.
Main Methods:
- Focus on resonant waveguide grating (RWG) biosensor technology for cellular assays.
- Discuss the application of these biosensors in analyzing cancer cell signaling.
Main Results:
- RWG biosensors are integrative tools for mining cancer cell surface markers.
- These biosensors facilitate the discovery of core cancer receptor signaling pathways.
Conclusions:
- Next-generation anti-cancer therapies require understanding oncogenic pathway dysregulation.
- Integrative biosensor cellular assays provide advantages in cancer biology characterization but face challenges in mechanism validation.
